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Abstract We examined the effects of interferon-K on the ATP-
sensitive K+ current (IK;ATP) in rabbit ventricular cells using the
patch-clamp technique. IK;ATP was induced by NaCN. Whole-
cell experiments indicated that interferon-K (5U102^2.4U104
U/ml) inhibited IK;ATP in a concentration-dependent manner
(60.7 þ 7.5% with 2.4U104 U/ml). In cell-attached configura-
tion, interferon-K (2.4U104 U/ml) applied to the external
solution also inhibited the activity of the single ATP-sensitive
K+ (KATP) channel by 56.0 þ 5.8% without affecting the single
channel conductance. The inhibitory effect of IK;ATP by
interferon-K was blocked by genistein and herbimycin A, tyrosine
kinase inhibitors, but was not affected by N-(2-metylpiperazyl)-
5-isoquinolinesulfoamide (H-7), an inhibitor of protein kinase C
and cAMP-dependent protein kinase. These findings suggest that
interferon-K inhibits the cardiac KATP channel through the
activation of tyrosine kinase. The tyrosine kinase-mediated
inhibition of IK;ATP by cytokines may aggravate cell damage
during myocardial ischemia.
z 1999 Federation of European Biochemical Societies.
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1. Introduction
Interferon is a cytokine, which plays important roles in the
host defense mechanisms against viral infection and cancer. It
binds to speci¢c receptors on target cells including infected
cells, cancer cells and immune cells, resulting in the inhibition
of virus proliferation, the activation of immune cells and the
regulation of oncogenes [1]. The heart may be a target site for
interferon, as the production of various cytokines including
interferons by leukocytes increases during cardiovascular dis-
ease such as myocarditis, cardiomyopathy and ischemic heart
disease [2,3], and because these cytokines are known to aggra-
vate heart failure [2].
Recent studies have indicated that interferon activates ty-
rosine kinase via the speci¢c receptor-mediated mechanism [4].
This kinase was recently found to be an important modulator
in ion channels [5], including L-type Ca2 [6], Cl3 [7] and K
channels [8^11]. In the heart, the delayed recti¢er K [8] and
the KATP channels [11] were reported to be modulated by
tyrosine kinase.
The KATP channel plays important protective roles in the
heart. Activation of KATP channel shortens the action poten-
tial duration to reduce energy consumption, and protects the
cardiac cells against ischemia [12^14]. Since the secretion of
interferon is increased under cardiac pathological conditions,
where the KATP channel is likely to be activated [3], it is
important to examine the e¡ects of this cytokine on cardiac
IK;ATP. The aim of this study was to elucidate the regulatory
role of interferon in the KATP channel in single cardiac my-
ocytes.
2. Materials and methods
2.1. Cell isolation
Isolation of single ventricular cells and voltage-clamp experiments
were conducted as described [15]. Rabbits weighing 2^2.5 kg were
anesthetized by intravenous injection of 40 mg/kg pentobarbital and
500 IU heparin, then were killed by a blow to the neck. The excised
heart was retrogradely perfused with Ca2-free, phosphate-bu¡ered
solution containing (in mM): NaCl, 142; KCl, 5.4; MgCl2, 1.0;
NaH2PO4, 0.33; Na2HPO4, 2.24; and glucose, 10 (pH = 7.4) for
10 min. The perfusates were then switched to the Ca2-free solution
containing 0.02 mg/ml collagenase (Yakult, Tokyo, Japan) and 0.01
mg/ml protease (Type 14, Sigma, St. Louis, MO, USA) for 15 min.
The perfusates were continuously bubbled with 100% O2 at 37‡C.
After a 10 min perfusion of the ¢rst enzyme treatment, the right
ventricular free wall was cut into small pieces. They were then stirred
in the second enzyme solution containing 1 mg/ml collagenase (Wako,
Osaka, Japan). Isolated cells were placed in the stock solution at 4‡C
with 0.1% bovine serum albumin (Sigma, Fraction V). The stock
solution contained (in mM): K-glutamate, 90; oxalate, 10; KCl, 25;
KH2PO4, 10; MgSO4, 1; taurine, 10; ethylene glycol-bis(L-aminoeth-
yl ether)-N,N,NP,NP-tetraacetic acid (EGTA), 0.5; N-2-hydroxyethyl-
piperazine-NP-2-ethanesulfonic acid (HEPES), 5; and glucose,
10 (pH = 7.2 adjusted with KOH).
2.2. Electrical measurements
For electrical measurements an Axopatch-1D ampli¢er was used
(Axon Instruments, Foster City, CA, USA). For whole-cell current
measurements, the cells were voltage-clamped under superfusion with
glucose-free Tyrode solution containing (in mM): NaCl, 140; KCl,
5.4; CaCl2, 1.0; MgCl2, 1.0 and HEPES, 5 (pH = 7.4 adjusted with
HCl). The pipette solution contained (in mM): K-aspartate, 110;
KCl, 20; CaCl2, 1.0; MgCl2, 1.0; EGTA, 10; K2-ATP, 1; Na3-
GTP, 0.2; and HEPES, 5 (pH = 7.2 adjusted with KOH). The pipette
used had a tip resistance of 2^2.5 M6. The cell capacity was 84 þ 18
pF (n = 135, mean þ S.D.). For induction of IK;ATP, the cells in the
recording chamber were pretreated with 1-mM NaCN-containing glu-
cose-free Tyrode solution for 10^20 min at 37‡C. During the voltage-
clamp experiments the concentration of NaCN in the superfusate was
increased to 10 mM to e¡ectively activate IK;ATP (Fig. 1A).
FEBS 21555 19-2-99
0014-5793/99/$19.00 ß 1999 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 9 9 ) 0 0 0 8 3 - 6
*Corresponding author. Fax: (81) (75) 251-5678.
E-mail: yhabuchi@koto.kpu-m.ac.jp
Abbreviations: IK;ATP, ATP-sensitive K current ; KATP channel,
ATP-sensitive K channel; PKC, protein kinase C; PKA, cAMP-
dependent protein kinase; H-7, N-(2-metylpiperazyl)-5-isoquinoline-
sulfoamide ; EGTA, ethylene glycol-bis(L-aminoethyl ether)-
N,N,NP,NP-tetraacetic acid; HEPES, N-2-hydroxyethyl-piperazine-NP-
2-ethanesulfonic acid
FEBS 21555 FEBS Letters 445 (1999) 87^91
Single-channel recordings were conducted in both the cell-attached
and inside-out con¢gurations [16]. The pipette’s resistance was around
10 M6. The pipette was heat-polished immediately before use and the
shank coated with Sylgard (Dow Corning Co., Midland, MI, USA).
The pipette solution contained (in mM): NaCl, 140; KCl, 5.4; and
HEPES, 5 (pH = 7.2 adjusted with KOH). For the cell-attached con-
¢guration, NaCN (1 mM) was added to the stock solution (4‡C) 4^6 h
before the use of the cells. The NaCN-loaded cells were perfused with
the bathing solution containing (in mM): KCl, 135; MgCl2, 2.0;
EGTA, 5; NaCN, 10; and HEPES, 5 (pH 7.4 adjusted with KOH).
Cromakalim (10 WM) was added to the perfusate to maintain the
single channel activity. In the inside-out mode, the excised patch
from the non-loaded cell was exposed to a bathing solution containing
(in mM): KCl, 135; MgCl2, 1.0; EGTA, 5; NaCN, 10; HEPES, 5;
ATP, 0.02; and ADP, 0.1 (pH 7.2 adjusted with KOH). All the ex-
periments were carried out at 37‡C.
2.3. Data acquisition and analysis
The frequencies of the low-pass ¢lter (E-3201B, NF Electrics, Osa-
ka, Japan) were 0.5 kHz for the whole-cell recording and 2 kHz for
the single-channel recording, respectively. In the single-channel experi-
ments, the data were analyzed using pClamp software (Axon Instru-
ments, Foster City, CA, USA). The mean open probability was meas-
ured every 15 s.
The data were presented as means þ S.E.M., unless otherwise speci-
¢ed. Student’s t-test was used for statistical analysis, and P values
smaller than 0.05 were considered to be signi¢cant.
2.4. Drugs and chemicals
We used interferon-K, provided by Sumitomo Pharmaceutical Co.
(Osaka, Japan). Interferon-K was stored at 4‡C as a 3.47U106 U/ml
stock solution in distilled water. Glibenclamide, Na2-ATP, K2-ATP,
ADP, Na2-phosphocreatine and Na3-GTP were purchased from Sig-
ma. All other chemicals were from Wako Pure Chemicals (Osaka).
Glibenclamide was dissolved in dimethylsulfoxide as a 10 or 100 mM
stock solution.
3. Results
3.1. Interferon-K inhibition of IK ;ATP
Fig. 1A shows a representative e¡ect of interferon-K on
IK;ATP in whole-cell con¢guration at a membrane potential
of 310 mV. After pretreatment with 1 mM NaCN, switching
of the solution to that containing 10 mM NaCN produced the
immediate activation of glibenclamide-sensitive IK;ATP [15].
During the plateau following the initial run-down of IK;ATP,
the bath application of interferon-K at 2.4U104 U/ml inhib-
ited the IK;ATP by 60.7 þ 7.5% (n = 16). In Fig. 1B, inhibitory
e¡ects on IK;ATP at 310 mV are plotted against the concen-
tration of interferon-K. Interferon-K inhibited IK;ATP in a con-
centration-dependent manner; it began to inhibit IK;ATP at
0.05U104 U/ml (10.1 þ 11%, n = 4).
Fig. 2A shows the e¡ect of interferon-K (2.4U104 U/ml) on
the single-channel current using the cell-attached con¢gura-
tion. Bath application of interferon-K signi¢cantly reduced
the channel openings. The mean NPo decreased by
56.0 þ 5.8% during superfusion with interferon-K (n = 10,
Fig. 2A,C). However, interferon-K at 2.4U104 U/ml did not
alter NPo when it was applied to the bath solution in the
inside-out con¢guration (n = 4, Fig. 2C). These results indicate
that the site for interferon-K to modify the KATP channel is on
the outer surface of the membrane. The I-V relationships for
single KATP channel (Fig. 2B) clearly show that interferon-K
did not change the conductance of the single KATP channel
(25.2 þ 0.3 pS during control and 25.4 þ 0.3 pS in the presence
of interferon-K, n = 6). Therefore, the inhibition of IK;ATP by
interferon-K is attributed to a decrease in the open probability
of the channels.
3.2. E¡ect of protein kinase inhibitors on inhibition of IK ;ATP
by interferon-K
Interferon-K induces tyrosine phosphorylation, which is a
key mediator of the receptor-e¡ect couplings of interferon in
various cells [4,17]. To assess the involvement of tyrosine kin-
ase in the IK;ATP inhibition by interferon-K, we examined the
e¡ects of interferon in the presence of tyrosine kinase inhib-
itors, genistein and herbimycin A. Either genistein at 100 WM
or herbimycin A at 1.5 WM was applied to the cell milieu
through the pipette. Fig. 3A shows the e¡ect of genistein.
Both genistein (n = 6) and herbimycin A (n = 6, data not
shown) completely blocked the inhibitory e¡ect of interfer-
on-K on IK;ATP. The e¡ect of genistein was also observed in
non-dialyzed cells. Fig. 3C shows the e¡ect of genistein on
KATP channels in the cell-attached con¢guration. The cells
were incubated with 10 WM genistein in the stock solution
for 4^6 h before use, and superfused with the bath solution
containing genistein (100 WM). Interferon-K (2.4U104 U/ml)
did not signi¢cantly a¡ect the single KATP channel activity in
the presence of genistein.
The aforementioned results indicate that the interferon-K
inhibition of IK;ATP is mediated by tyrosine kinase. KATP
channels are known to be regulated by other protein kinases
including protein kinase C (PKC) [18] and protein kinase A
(PKA) [19]. The possibility that PKA and PKC is involved in
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Fig. 1. E¡ects of interferon-K on IK;ATP. A: Representative record
of the holding current at 310 mV. The pipette solution contained
1 mM ATP. Horizontal bars indicate the period of extracellular ap-
plications of the drugs. The concentrations of interferon-K and glib-
enclamide were 2.4U104 U/ml and 1 WM, respectively. NaCN was
¢rst applied at a concentration of 1 mM. After the whole-cell con-
¢guration was established, the concentration of NaCN was in-
creased to 10 mM. The dotted line indicates the baseline current
level obtained by the application of glibenclamide. B: Concentra-
tion-dependent inhibitions of IK;ATP by interferon-K. The IK;ATP in
the presence of interferon-K relative to that immediately before the
application of interferon-K is plotted against the interferon-K con-
centration. IK;ATP was measured as the glibenclamide-sensitive cur-
rent. Parentheses indicate the number of cells. A single concentra-
tion of the drug was tested on one cell.
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the interferon-induced inhibition of IK;ATP was examined us-
ing 100 WM H-7, an inhibitor for PKC and PKA, in the
pipette solution. H-7 did not a¡ect the inhibition of IK;ATP
by interferon-K (59.4 þ 6.3%; n = 6; Fig. 3B).
4. Discussion
Our results showed that interferon-K inhibited IK;ATP in
rabbit ventricular myocytes. The inhibitory e¡ect of interfer-
on-K occurred when the outer membrane surface was exposed
to interferon-K. The attenuation of IK;ATP by interferon-K was
blocked by the application of genistein and herbimycin A,
tyrosine kinase inhibitors. It has been generally regarded
that interferons exert their cellular e¡ects by binding to the
speci¢c receptors of target cells [23,26]. Interferon-bound re-
ceptors activate a family of tyrosine kinases, known as Janus
kinases [4,23,27]. These tyrosine kinases are key mediators in
the interferon receptor-response couplings. Thus, our ¢nding
that the extracellular application of interferon-K inhibited
IK;ATP via activation of tyrosine kinase indicates that interfer-
on-K induced the suppression of IK;ATP through the physio-
logical receptor-response couplings.
Since tyrosine kinases phosphorylate tyrosine residues of
various proteins [28], interferon-K may inhibit IK;ATP by phos-
phorylating the channel protein. Indeed, Kwak et al. [11]
demonstrated that tyrosine phosphorylation of the KATP
channel prompted the run-down of the channel activity in
the inside-out con¢guration in rat cardiac myocytes. Using a
cloned KATP channel, Ashford et al. [29] and Inagaki et al.
[30] found that the KATP channel has sites sensitive to tyrosine
phosphorylation. The tyrosine phosphorylation was reported
also in other K channels, such as the delayed-recti¢er K
(RAK) channel [8], cloned Kv3.1 and Kv2.1 channels [31] and
the voltage-gated K channel in Aplysia bag-cell neurons [10].
Huang et al. [8] found that the RAK channel inhibition by
muscarinic stimulation was absent in the mutant RAK chan-
nel lacking tyrosine phosphorylation sites. Based on these
¢ndings, it seems that tyrosine kinases participate in the func-
tional regulation of various types of membrane K channels,
and that interferon modulates IK;ATP through tyrosine phos-
phorylation of the channel protein.
The phosphorylation of various channel proteins plays a
key role in the regulation of the channel function [32]. PKA
and PKC, rather than tyrosine kinase, are known to cause
large and rapid changes in various ionic currents. IK;ATP is
also regulated by the phosphorylation of PKA and PKC
[18,19,33]. In addition, PKC regulates the tyrosine kinase
[34], and recent electrophysiological studies have also shown
that PKC-mediated tyrosine kinase activation is involved in
the muscarinic suppression of KATP and RAK channels [8,35].
PKA may also modify tyrosine phosphorylation of channel
proteins [10]. However, our ¢nding that H-7 did not alter the
e¡ects of interferon-K in this study indicates that PKA and
PKC played a small, if any, role in the inhibition of IK;ATP by
interferon-K.
Tyrosine phosphorylation is closely related with gene tran-
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Fig. 2. Interferon-K inhibition of single KATP channels in the cell-attached con¢guration. A: Upper trace, single-channel recording in the ab-
sence (a) and presence (b) of interferon-K (2.4U104 U/ml). The membrane potential was maintained at 310 mV. Interferon-K was added to the
bath solution. The dotted line indicates 0-current level, which was determined by applying 1 WM glibenclamide at the end of the experiment.
Lower panel, temporal change in the open probability of the KATP channels following the application of interferon-K. The NPo measured every
15 s is plotted as a function of time. The horizontal bar indicates the period of interferon-K (2.4U104 U/ml) application. The channel record-
ings indicated by (a) and (b) in this panel are shown as the upper traces. B: Conductance of the single KATP channel current. a and b denote
the single-channel amplitude at various holding potentials before and after the application of interferon-K (2.4U104 U/ml), respectively (n = 6).
C: The e¡ects of interferon-K on NPo in cell-attached and inside-out con¢gurations. The NPo was averaged for a period of 1 min immediately
before and after the application of interferon-K (2.4U104 U/ml). The relative NPo denotes the ratio of the averaged NPo during the interferon-
K perfusion to that during control. Parentheses indicate the number of cells.
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scription [4,27]. The interferon-activated Janus kinases phos-
phorylate some protein complexes (interferon-stimulated gene
factors). The phosphorylated gene factors induce gene tran-
scription and cause the e¡ects. Interferon-K is reported to
induce gene transcription within minutes in human ¢broblast
cells [21]. Therefore, it is possible that some e¡ectors following
interferon-induced gene transcription inhibit IK;ATP.
Our experiments demonstrated that bath-applied interferon-
K inhibited the KATP channel activity at a threshold concen-
tration of 500 U/ml. In previous reports, experimental con-
centrations between 200^1000 U/ml [21^24] were used for hu-
man interferon to stimulate human cells ; i.e. a high dose of
interferon seems to be necessary for the inhibition of IK;ATP.
The tissue concentration of interferon has not yet been deter-
mined. The cytokine secretion, including interferons, exhibits
an autocrine property [20]. Therefore, the concentration of
interferon may be high in tissues, in su⁄cient amounts to
modulate IK;ATP. In addition, in our experiments we used
human interferon-K and rabbit cardiac cells. The interferon-
receptor reaction is highly species-dependent and shows only a
weak cross reaction [25]. Thus, the use of the cardiac cells
isolated from di¡erent species may have diminished the activ-
ity of human interferon in this study.
In summary, we showed that cardiomyocytes are a target of
interferon-K, which regulates IK;ATP via tyrosine kinase-medi-
ated mechanisms. Cytokines such as tumor necrosis factor,
interleukins, and interferons are expressed during heart failure
and aggravate the condition [2,3,20,36]. Therefore, the inhib-
ition of IK;ATP by interferons may diminish the cardioprotec-
tive mechanisms of the KATP channel and may aggravate cell
damage during ischemia. This is the ¢rst report showing that
a biological cytokine modulates cardiac IK;ATP through tyro-
sine kinase.
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